Stock Events

Stock Events

Alnylam Pharmaceuticals (A1LN34.SA) Q2 2017 Earnings

5MayConfirmed

Q3 2016

Q4 2016

Q1 2017

Q2 2017

-4.27

-3.96

-3.65

-3.34

Details

Expected EPS

-4.001571

Actual EPS

-3.9698125

Surprise EPS

0.03

Surprise Percent

+0.79%

Description

Alnylam Pharmaceuticals (A1LN34.SA) has reported earnings of -3.9698125 per share for Q2 2017.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.